Skip to main content

Sanofi-Aventis Deutschland GMBH v. Mylan Pharmaceuticals Inc.

Certiorari Denied

Petition for certiorari denied on October 5, 2020.

Docket No.19-1451
Op. BelowFed. Cir.
SCOTUS Page

Issue

(1) Whether, in a pending case, a court can refuse to entertain a constitutional, separation-of-powers challenge based on an intervening change of law on the grounds of forfeiture; and (2) whether the U.S. Court of Appeals for the Federal Circuit"s obviousness holding is an unwarranted expansion of the Supreme Court"s decision in KSR International Co. v. Teleflex Inc. and is inconsistent with the Patent Act.

Proceedings & orders timeline

Jun 26, 2020
Petition for a writ of certiorari filed. (Response due August 3, 2020)Jul 28, 2020
Motion to extend the time to file a response from August 3, 2020 to August 24, 2020, submitted to The Clerk.
Jul 29, 2020
Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2020.
Aug 24, 2020
Brief of respondent Mylan Pharmaceuticals Inc. in opposition filed.Sep 8, 2020
Reply of petitioner Sanofi-Aventis Deutschland GmbH filed. (Distributed)
Sep 9, 2020
DISTRIBUTED for Conference of 9/29/2020.
Oct 5, 2020
Petition DENIED.

Welcome to SCOTUSblog

Tell us a bit about yourself so we can tailor what you see. You can update these any time in your account.